Shenzhen Innosyn Biotech, established in 2012, manufactures amino acid derivatives and chiral building blocks used in peptide and API synthesis, including sarcosine, N-methyl-L-isoleucine, Boc- and Fmoc-protected amino alcohols, and S-configured propranolol hydrochloride. The company offers CRO, CMO, and CDMO contract services to customers across North America, Europe, Asia, the Middle East, and Africa.
No comments available.
Leave your rating & comment